Clinical trial
Phase Ⅱ/Ⅲ Study of Preoperative Concurrent Chemoradiotherapy for Locally Advanced Gastroesophageal Junction or Upper Gastric Adenocarcinoma
NCT02193594 is registered in ClinicalTrials.gov with Peking University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase Ⅱ/Ⅲ Study of Preoperative Concurrent Chemoradiotherapy for Locally Advanced Gastroesophageal Junction or Upper Gastric Adenocarcinoma
- Lead sponsor
- Peking University
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- January 31, 2014
- Completion date
- May 31, 2020
- Enrollment
- 214 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastroesophageal junction adenocarcinoma